Zentalis Pharmaceuticals Llc (ZNTL) — Long-term Investment Intensity
Zentalis Pharmaceuticals Llc (ZNTL) has a Long-term Investment Intensity of 3.9% as of March 2023. Long-term investments of $18.90 Million represent 3.9% of total assets of $489.34 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ZNTL asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zentalis Pharmaceuticals Llc Long-term Investment Intensity (2021–2022)
This chart shows how Zentalis Pharmaceuticals Llc's Long-term Investment Intensity has evolved across 2 annual periods from 2021 to 2022. As of March 2023, the intensity stands at 3.9%, reflecting long-term investments of $18.90 Million against total assets of $489.34 Million USD. For the complete balance sheet picture, see ZNTL asset base.
Annual Long-term Investment Intensity for Zentalis Pharmaceuticals Llc (2021–2022)
The table below presents the year-by-year Long-term Investment Intensity for Zentalis Pharmaceuticals Llc from 2021 to 2022, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Zentalis Pharmaceuticals Llc carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 3.8% | $21.21 Million | $553.46 Million | ▼ -4.1 pp |
| 2021 | 7.9% | $37.49 Million | $472.02 Million | — |